Lilly’s new GLP-1 pill had 1,390 prescriptions in its first week on the market.
www.marketwatch.com
#Lillys #GLP1 #pill #robust #start
Lilly’s new GLP-1 pill is off to a ‘robust’ start
Related Posts
Amazon-backed Anthropic rolls out Claude AI for financial services
Dario Amodei, Anthropic CEO, speaking on CNBC’s Squawk Box outside the World Economic Forum in Davos, Switzerland on Jan. 21st, 2025.…
Micron’s stock has boomed on AI optimism. Now comes the ‘tricky part.’
One analyst says the next leg of the Micron rally needs to come from something other than what’s driven the…
How that impacts consumer costs
ContentsRead more CNBC personal finance coverageHow the Fed affects your financesA changing of the guard A shopper carries a…